Ashland Inc. · NYSE:ASH
Ashland — Investor Presentation (September 2021)
15 slides from Ashland's investor presentation, September 2021
Slide 1: GPM Lutein
gom™ lutein <t Ashland’ oe wierd on / efficacy usability allure integrity profitability always solving
Slide 2: GPM Lutein
gpm™ lutein
Slide 3: Health concern: increased exposure to blue light
health concern: increased exposure to blue light — • Blue light has shorter wavelengths and more energy vs other colors in the visible spectrum • There are many sources of blue light • CFL bulbs, LED bulbs, flat LED screens, computer monitors, tablets, smart phones • The sources of blue light are in
Slide 4: Blue light at night also disturbs night-time processes and sleep
blue light at light also disturbs night-time processes and sleep — 4
Slide 5: Lutein and bilberries are common ingredients in eye health supplements
lutein and bilberries are some of the most common ingredients used in supplements for eye health support 5 Source: Innova Market Insights, North America new product launches
Slide 6: Featured ingredient: GPM Lutein
featured ingredient: gpm™ lutein — PRODUCT DESCRIPTION GPM™ Lutein is one of our patented, fermented vitamins. Lutein is a type of naturally occurring carotenoid called a xanthophyll. Xanthophylls are found in green leafy vegetables like spinach and kale. Lutein acts like an antioxidant. It is belie
Slide 7: In vivo studies
in vivo studies
Slide 8: In vitro study of GPM Lutein
in vitro study of gmp™ lutein — study of the protective benefits against pro-oxidant / pro-inflammatory / pro- aging stresses ex vivo Goal: evidence beneficial activity ex vivo against oxidation, inflammation, aging Models: cultured cells and 3D tissue models (retinal pigmented epithelium) Stre
Slide 9: ARPE-19 cell viability impaired by UVB stress – protective effect of lutein
ARPE-19 cells viability is impaired by UVB stress – protective effect of lutein — Lutein Lutein D0 D1 D2 UVB viability 50 mJ/cm2 • GPM Lutein was able to prevent cell viability loss after a 50 mJ/cm² UVB stress. • The cell viability loss was only 15.1% with GPM Lutein compared to 24.3% loss with sta
Slide 10: Basal level of senescence in ARPE19 cells – effect of lutein
basal level of senescence in ARPE19 cells – effect of Lutein — 120 100 Beta galactosidase activity (in %) 100 -39.5%* -31.8%* 80 60.5 68.2 60 40 20 0 CTR Lutein Lutein GPM GPM Lutein showed better ability to reduce the basal level of senescence 10 observed in ARPE19 cells in these conditions compare
Slide 11: H2O2-induced oxidative stress – effect of lutein
H2O2-induced oxidative stress – effect of lutein — ARPE-19 LUTEIN 1µg/ml with H2O2 stress 700 -18.1% 1 ppm Lutein GPM powder (10% lutein) 1 ppm Lutein powder (75% lutein) diluted 7.5 times -12.7% p=1.10-6*** 581 Mean Relative Fluorescence Intensity 600 p=0.0007** -12.4% -9.2% p=0.0002*** 499 507 Onl
Slide 12: GPM Lutein testing summary
gpm™ lutein testing summary — • The cell line ARPE19 was successfully used to develop a cohesive monolayered epithelium. • GPM™ Lutein was able to prevent ARPE19 cell viability loss after a 50 mJ/cm² UVB stress. The cell viability loss was only 15.1% with GPM Lutein compared to 24.3% loss with stand
Slide 13: GPM nutrients
— GPM™ nutrients • GPM™ lutein is just one nutrient in the broader portfolio of GPM™ nutrients • GPM™ nutrients are available in soy- free and organic versions 13
Slide 14: Disclaimer
14 disclaimer The information contained in this presentation and the various products described are intended for use only by persons having technical skill and at their own discretion and risk after they have performed necessary technical investigations, tests and evaluations of the products and the
Slide 15: Ashland
oT <t Ashland always solving